Novartis AG (NYSE:NVS)
100.93 Delayed Data As of Jun 09 | ![]() Today’s Change | 74.09 Today|||52-Week Range 105.56 | +11.25% Year-to-Date |
Latest NVS News | Press Releases
Today’s Trading
Previous close | 100.65 |
Today’s open | 100.32 |
Day’s range | 99.68 - 101.02 |
Volume | 3,168,391 |
Average volume (3 months) | 2,174,499 |
Market cap | $207.5B |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
Earnings growth (last year) | -70.23% |
Earnings growth (this year) | +10.80% |
Earnings growth (next 5 years) | +5.10% |
Revenue growth (last year) | -2.09% |
P/E ratio | 31.0 |
Price/Sales | 3.94 |
Price/Book | 3.53 |
Competitors
Today’s change | Today’s % change | |
---|---|---|
PFEPfizer | -0.12 | -0.31% |
AZNAstraZeneca | -0.19 | -0.26% |
ABBVAbbVie | +0.50 | +0.36% |
NVONovo Nordisk | -1.38 | -0.87% |
Data as of 4:00pm ET, 06/09/2023
Financials
Next reporting date | July 18, 2023 |
EPS forecast (this quarter) | $1.69 |
Annual revenue (last year) | $50.5B |
Annual profit (last year) | $7.0B |
Net profit margin | 13.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
